Ambixol, Ambroxol

Drugs acting upon the Pulmonary System

INN: Ambroxol

Код АТХ: R05CB 6

Composition:

5 ml syrup contain 15 mg Ambroxol hydrochloride.

Indications:

Secretolytic therapy in acute and chronic diseases of upper and lower respiratory tracts, accompanied by increased viscous secretion and impaired mucous conduction.

Dosage and administration:

Ambroxol syrup is administered orally during meals. In adults and children over 12 years, in acute disorders or as initial therapy in chronic disorders, therapy begins at a dose of 30 mg (10 ml syrup – 2 teaspoonfuls), 3 times daily during the first 2-3 days and then the dose can be reduced by half – 5 ml (1 teaspoonful) 3 times daily. In children from 6 to 12 years: 5 ml (1 teaspoonful) 2-3 times daily; from 2 to 6 years - 2,5 ml (1/2 teaspoonful) 3 times daily; from 1 to 2 years – 2,5 ml (1/2 teaspoonful) 2 times daily; under 1 year – not recommended. Administration of the product for over 5 days without physician’s consultation is not recommended.

Contraindications:

Hypersensitivity to the product.

Drug interactions:

Concomitant administration of Ambroxol and antibiotics (amoxicillin, cefuroxime, erythromycin, doxycyclin) leads to higher concentration of the antibiotic in the pulmonary tissue.Co-administration of Ambroxol and cough-suppressing preparations is not recommended. Clinically significant interactions of Ambroxol with other medicinal substances have not been reported.

Adverse reactions:

This medicinal product is usually well tolerated. It rarely causes dyspeptic disorders, allergic rashes, headache. There are insufficient data of its safety in pregnant and lactating women.

Supplied:

Syrup in vials of 100 ml.

Dispensing:

Without prescription.

Back to Top!